lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

The PCNP/β-Catenin Axis Promotes Ovarian Cancer Progression

24 Pages Posted: 29 Sep 2019

See all articles by Pengzhen Dong

Pengzhen Dong

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

Huimin Li

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

Hao Fu

Henan University - Huaihe Hospital

Shihui Zhang

Henan University

Xin Zhang

Henan University

Yage Chen

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

Tao Li

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

Dongdong Wu

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

Xinying Ji

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

More...

Abstract

PCNP is associated with human cancers including neuroblastoma and lung cancer. However, the role and underlying molecular mechanism of PCNP have not been plenty elucidated. Herein, we first investigated the effects of PCNP in ovarian cancer proliferation, apoptosis, migration and invasion and determined the molecular mechanism of PCNP in ovarian cancer progression. The results indicated that PCNP was significantly overexpressed in human ovarian cancer tissues and cells, and related to poor prognosis in ovarian cancer patients. In addition, we also detected that PCNP promoted ovarian cancer cells growth, migration and invasion, as well as inhibited ovarian cancer cells apoptosis. Mechanistically, PCNP bound to β-catenin, promoted β-catenin nuclear translocation and further activated Wnt/β-catenin signaling pathway. Moreover, PCNP regulated the expression of genes involved in EMT and further triggered EMT occurrence. Together, these results summarized that PCNP/β-catenin axis may promote ovarian cancer progression, supplying a novel and promising targets to improve prognosis and treat ovarian cancer.

Funding Statement: The research was supported by two National Natural Science Foundation of China (81670088, 81602708) and Henan Provincial Science and Technology Department International Cooperation Project (172102410019).

Declaration of Interests: The authors declare no potential conflicts of interest.

Ethics Approval Statement: This study was reviewed and approved by the Ethical Board at Henan University. All animal procedures were manipulated with the approval of the Medical and Research Ethics Committee of Henan University Medical School.

Keywords: OC; PCNP; Wnt/β-catenin; EMT

Suggested Citation

Dong, Pengzhen and Li, Huimin and Fu, Hao and Zhang, Shihui and Zhang, Xin and Chen, Yage and Li, Tao and Wu, Dongdong and Ji, Xinying, The PCNP/β-Catenin Axis Promotes Ovarian Cancer Progression (September 27, 2019). Available at SSRN: https://ssrn.com/abstract=3460626 or http://dx.doi.org/10.2139/ssrn.3460626

Pengzhen Dong

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

Kaifeng
China

Huimin Li

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

Kaifeng
China

Hao Fu

Henan University - Huaihe Hospital

Kaifeng
China

Shihui Zhang

Henan University

85 Minglun St. Shunhe
Kaifeng, Henan 475001
China

Xin Zhang

Henan University

85 Minglun St. Shunhe
Kaifeng, Henan 475001
China

Yage Chen

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

Kaifeng
China

Tao Li

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation

Kaifeng
China

Dongdong Wu (Contact Author)

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation ( email )

Kaifeng
China

Xinying Ji

Henan University - Henan International Joint Laboratory for Nuclear Protein Regulation ( email )

Kaifeng
China